In this episode of Research Renaissance, Deborah Westphal sits down with Dr. Grant Mitchell, co-founder and CEO of Every Cure — a nonprofit revolutionizing how we treat disease using artificial intelligence and drug repurposing.

You’ll hear the incredible true story behind the organization’s founding: a rare disease, a near-death diagnosis, and the life-saving power of finding the right drug at the right time — one that was already FDA-approved but never intended for that disease.

Dr. Mitchell unpacks how Every Cure is:

• Using AI to map connections between 4,000+ FDA-approved drugs and 20,000+ diseases.
• Tackling the “organizational problem” in medical research — not just the scientific one.
• Building a nonprofit model that bypasses commercial incentives to focus purely on patient outcomes.
• Launching a new public platform that will allow researchers, doctors, and even patients to explore potential drug-disease matches.

💡 From real-world case studies to a bold vision for transforming clinical trial timelines, this is an inspiring and eye-opening look at how a small team might just be out-innovating Big Pharma — and doing it faster, cheaper, and with more heart.

Resources Mentioned:

• Visit everycure.org to learn more or get involved.
• Contact Grant directly at [email protected]
• Learn more about the Karen Toffler Charitable Trust at tofflertrust.org

Never miss an episode of Research Renaissance — subscribe on your favorite podcast platform and follow us at tofflertrust.org for updates.

To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.

Technical Podcast Support by Jon Keur at Wayfare Recording Co.